Project Grant 2052243
Award Date
7/15/21
Completion Date
6/30/22
Dollars Obligated
$253K
Federal Agency
Division of Industrial Innovation
Awardee
Insoma Bio, Inc. (LF3PGT7RN6G7)
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Durham, NC 27701, USA
Similar Awards
Insoma Bio, Inc., a for-profit biotechnology company, was awarded a $979,197 Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program to develop an injectable protein matrix to enhance the stability of autologous fat grafts for craniofacial reconstruction. The 2-year project aims to improve clinical outcomes for patients undergoing facial reconstructive surgery by addressing the common challenges of volume and shape loss...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) is supporting the development of an optimized, off-the-shelf alternative to autologous fat grafting for soft tissue repair. The $293,983 award to Insoma Bio, Inc., a biotechnology company in Durham, North Carolina, will evaluate the combination of Insoma Bio's Fractomer tissue repair matrix and the Renuva adipose allograft material from MTF...
Biosapien Inc. received a $256,000 Project Grant award from the National Science Foundation on May 1, 2021 to develop a novel 3D printed biodegradable mesh delivering active pharmaceutical ingredients in a sustained and localized manner under the Small Business Innovation Research Phase I program. The SBIR Phase I grant supports the proof-of-concept stage of developing Biosapien's technology, with the work expected to be completed by June 30, 2022. The NSF Technology, Innovation, and...
This Project Grant award from the National Science Foundation (NSF), under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084), provides $275,000 to Mellicell Inc. to develop an industrial-scale technology for drug development using mature human fat cells. The broader impact of this SBIR Phase I project is to enable the discovery and development of next-generation therapeutics for obesity and associated medical conditions that can be treated through weight loss. The award will...
The National Science Foundation (NSF) awarded a $540,000 Project Grant through its Directorate for Engineering (CFDA 47.041) to Purdue University in West Lafayette, Indiana. The funding will support research to examine how the composition and physical properties of the extracellular matrix (ECM) affect the dysfunction of adipocytes (fat cells) and obesity-related inflammation. Specifically, the project will investigate the impacts of hyaluronic acid avidity, stress relaxation, and stiffness of...
This $516,000 Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program will support the development of injectable cellulose-based hydrogels for soft tissue bulking from July 1, 2022 to June 30, 2024. The Research Foundation of the City University of New York, in partnership with the City University of New York, will engineer a stable yet reversible injectable soft tissue filler material derived from plant polysaccharides like cellulose. If successful,...
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Current Surgical Inc. from May 15, 2021 to November 30, 2021 under the Engineering program (CFDA 47.041). The grant funds the development of a smart needle for precise tumor ablation. The NSF Engineering program supports innovation, creativity, and excellence in engineering research and education to improve quality of life and economic strength. This award advances those goals by...
This three-year, four hundred thirty-five thousand eight hundred forty-five dollar ($435,845) Project Grant from the National Science Foundation's Division of Chemical, Bioengineering, Environmental, and Transport Systems will support Carnegie Mellon University's efforts to advance biom anufacturing of vascularized adipose tissues. Specifically, the university aims to address engineering challenges in producing large, high-density human adipose tissues with integrated, perfusable vascular...
This $241,823 federal Project Grant award from the National Science Foundation's (NSF) Engineering program (CFDA 47.041) supports the development of an implantable engineered tissue with optogenetically engineered human beta-cells. The project aims to address challenges in creating vascularized tissues with light-activatable cells to improve treatment for diabetes. Key activities include designing a gelatin-based engineered tissue with oxygen-generating microparticles and optogenetically...
The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to develop an automatic debridement device from August 1, 2021 through March 31, 2022. This Small Business Innovation Research Phase I award under the Engineering (47.041) program will support the creation of a product to automatically remove dead, damaged, or infected tissue. The NSF Directorate for Engineering seeks to foster innovation and excellence in engineering research, consistent with...